This Biotech Startup Just Raised $47 Million To Make Drugs From Fungi

Hexagon Bio wants to discover more medicinal uses for fungi (though this time, it will be on purpose). On September 15th, the company announced that it raised a $47 million Series A round that will help it genetically sequence fungi and find new breakthrough medications. The next penicillin, the company wagers, is already out there waiting to be discovered.